Vimarsana
Biggest News Aggregation in the World

Page 19 - Robert Michael News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Michael. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Michael Today - Breaking & Trending Today

JANET CHUICH | News, Sports, Jobs - The Herald Star - Vimarsana News

JANET CHUICH | News, Sports, Jobs - The Herald Star

Janet I. Chuich, 74, passed away Thursday May 16, 2024 at The Kobacker House in Columbus, OH. She was born on September 7, 1949 to the late Walter Doyle Kieffer

Why is Jew-hatred and anti-Israelism on the rise? - The Jerusalem Post - Vimarsana News

Why is Jew-hatred and anti-Israelism on the rise? - The Jerusalem Post

As Jews are fighting a war of self-defense against Hamas, the PLO, and other terrorist organizations, Israel is accused of genocide, war crimes, and perpetrating a Holocaust.

Source: jpost.com
Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook - Landos Biopharma (NASDAQ:LABP), AbbVie (NYSE:ABBV) - Vimarsana News

Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook - Landos Biopharma (NASDAQ:LABP), AbbVie (NYSE:ABBV)

AbbVie impresses with Q1 results: EPS beats at $2.31 (-6.1% Y/Y), net revenue exceeds at $12.31 billion (+0.7%). Notable: Immunology sales, Humira vs. biosimilars, oncology gains.

AbbVie tries to reassure investors on Humira biosimilar threat - Vimarsana News

AbbVie tries to reassure investors on Humira biosimilar threat

BioPharma

AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q - Vimarsana News

AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q

By Sabela Ojea Shares of AbbVie lost 4.6% to close at $159.62 on Friday after the company warned about the effects of losing the exclusivity of its patent for the arthritis medication Humira,...